Article
Combined effects of hepatocyte nuclear factor 4α and constitutive androstane receptor on stable warfarin doses.
Pharmacogenetics and genomics - 1 Jan 2015
Moon Jung Yeon, Lee Kyung Eun, Chang Byung Chul, Jeong Eurim, Jeong Hotcherl, Gwak Hye Sun
Abstract excerpt
A possible association between the combination of genetic variations in hepatocyte nuclear factor 4α (HNF4α) and constitutive androstane receptor (CAR) and the stable doses of warfarin was examined in patients from the Ewha-Severance Treatment (EAST) Group of Warfarin. Around 42.5% of the overall interindividual variability in warfarin dose requirements was explained by the multivariate regression model; the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
